CCL2 and cancer: The downstream effects of the subnetwork influence such cancer hallmarks and biological effects as immune suppression, cell survival, cellular proliferation and migration, angiogenesis, EMT, invasion, and disease progression and via MCP‐1 potentially cabazitaxel resistance.